1. Home
  2. STVN vs TIGO Comparison

STVN vs TIGO Comparison

Compare STVN & TIGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • TIGO
  • Stock Information
  • Founded
  • STVN 1949
  • TIGO 1990
  • Country
  • STVN Italy
  • TIGO Luxembourg
  • Employees
  • STVN N/A
  • TIGO N/A
  • Industry
  • STVN Containers/Packaging
  • TIGO Telecommunications Equipment
  • Sector
  • STVN Consumer Discretionary
  • TIGO Telecommunications
  • Exchange
  • STVN Nasdaq
  • TIGO Nasdaq
  • Market Cap
  • STVN 6.6B
  • TIGO 6.0B
  • IPO Year
  • STVN 2021
  • TIGO 1994
  • Fundamental
  • Price
  • STVN $25.38
  • TIGO $38.02
  • Analyst Decision
  • STVN Buy
  • TIGO Buy
  • Analyst Count
  • STVN 6
  • TIGO 5
  • Target Price
  • STVN $25.08
  • TIGO $38.90
  • AVG Volume (30 Days)
  • STVN 322.5K
  • TIGO 1.2M
  • Earning Date
  • STVN 08-05-2025
  • TIGO 08-07-2025
  • Dividend Yield
  • STVN 0.24%
  • TIGO 8.01%
  • EPS Growth
  • STVN N/A
  • TIGO 5635.24
  • EPS
  • STVN 0.50
  • TIGO 2.06
  • Revenue
  • STVN $1,215,562,040.00
  • TIGO $5,691,000,000.00
  • Revenue This Year
  • STVN $8.69
  • TIGO N/A
  • Revenue Next Year
  • STVN $10.67
  • TIGO $2.39
  • P/E Ratio
  • STVN $50.81
  • TIGO $18.21
  • Revenue Growth
  • STVN 3.81
  • TIGO N/A
  • 52 Week Low
  • STVN $17.12
  • TIGO $23.61
  • 52 Week High
  • STVN $26.18
  • TIGO $38.92
  • Technical
  • Relative Strength Index (RSI)
  • STVN 59.00
  • TIGO 58.64
  • Support Level
  • STVN $23.64
  • TIGO $36.59
  • Resistance Level
  • STVN $26.18
  • TIGO $38.92
  • Average True Range (ATR)
  • STVN 1.11
  • TIGO 0.92
  • MACD
  • STVN 0.06
  • TIGO -0.01
  • Stochastic Oscillator
  • STVN 78.61
  • TIGO 70.63

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About TIGO Millicom International Cellular S.A.

Millicom offers wireless and fixed-line telecom services primarily in smaller, less developed countries in Latin America. Countries served include Bolivia (100% owned), Nicaragua (100%), Panama (100%), El Salvador (100%), Guatemala (100%), Paraguay (100%), Colombia (50%), and Honduras (67% but not controlled or consolidated in the firm's financial statements). The firm's wireless networks cover about 120 million people, serving 42 million customers. Its fixed-line networks reach 14 million homes, serving about 4 million broadband customers. Increasingly, Millicom offers converged packages that include broadband with wireless services. The firm has agreed to sell the majority of its wireless towers to SBA Communications for $975 million.

Share on Social Networks: